Thrive Capital Management (Pennsylvania)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.61M Sell
22,943
-2,809
-11% -$654K 1.23% 17
2025
Q4
$5.33M Sell
25,752
-3,091
-11% -$611K 1.19% 14
2025
Q3
$5.35M Buy
28,843
+3,237
+13% +$555K 1.38% 14
2025
Q2
$3.91M Buy
25,606
+10,396
+68% +$1.6M 1.23% 15
2025
Q1
$2.52M Sell
15,210
-6,615
-30% -$1.04M 1.51% 9
2024
Q4
$3.16M Buy
21,825
+5,764
+36% +$893K 1.45% 17
2024
Q3
$2.6M Sell
16,061
-1,229
-7% -$196K 1.23% 13
2024
Q2
$2.53M Buy
17,290
+3,722
+27% +$554K 1.15% 14
2024
Q1
$2.15M Buy
13,568
+6,183
+84% +$984K 1.14% 13
2023
Q4
$1.16M Buy
7,385
+316
+4% +$48.5K 0.62% 44
2023
Q3
$1.1M Sell
7,069
-191
-3% -$31.5K 0.61% 44
2023
Q2
$1.2M Buy
7,260
+798
+12% +$129K 0.69% 44
2023
Q1
$991K Buy
6,462
+189
+3% +$30.5K 0.63% 44
2022
Q4
$1.11M Buy
6,273
+620
+11% +$107K 0.72% 38
2022
Q3
$923K Sell
5,653
-6
-0.1% -$1.01K 0.62% 41
2022
Q2
$1M Sell
5,659
-356
-6% -$63.4K 0.7% 39
2022
Q1
$1.07M Sell
6,015
-3,471
-37% -$591K 0.64% 39
2021
Q4
$1.62M Sell
9,486
-1,704
-15% -$279K 1.06% 21
2021
Q3
$1.81M Sell
11,190
-451
-4% -$76.9K 1.33% 18
2021
Q2
$1.92M Buy
11,641
+288
+3% +$47.7K 1.49% 14
2021
Q1
$1.87M Sell
11,353
-33
-0.3% -$5.34K 1.74% 19
2020
Q4
$1.79M Buy
+11,386
New +$1.68M 1.91% 19

Other funds holding JNJ

Thrive Capital Management (Pennsylvania)'s JNJ Position: Q1 2026 in Review

Thrive Capital Management (Pennsylvania) reduced its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, selling an estimated $654K and leaving 22,943 shares worth $5.61M. The position accounts for 1.23% of the portfolio, ranked #17.

Thrive Capital Management (Pennsylvania) first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Thrive Capital Management (Pennsylvania) held 22,943 shares of Johnson & Johnson worth $5.61M as of Q1 2026.
  • Thrive Capital Management (Pennsylvania) sold 2,809 Johnson & Johnson shares in Q1 2026, an estimated $654K.
  • Johnson & Johnson made up 1.23% of Thrive Capital Management (Pennsylvania)'s portfolio in Q1 2026, its #17 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2026, filed 27 Apr 2026.